CV19 Lab Testing Dashboard powered by hc1
To support health care providers and public health agencies in responding to the COVID-19 pandemic,
hc1 is leading a coalition of 20K+ lab testing locations to power the CV19 Lab Testing Dashboard.

By Sarah Virgil

August 14, 2019

In a new Healthcare Financial Management Association (hfma) article, hc1 Senior Vice president of High-Value Care, Scott LaNeve, shares how automated clinical decision support can help healthcare providers follow prescribing guidelines to reduce opioid misuse and its costs.

He explains how tools for automated clinical decision support, like hc1 Opioid Advisor™, simplify the process of retrieving and analyzing PDMP and laboratory reports. They integrate laboratory and PDMP data within the electronic health record. Healthcare providers can have a single point of access and the automated process can include analytics that fit into the clinical workflow and flag potential high-risk situations based on comparing PDMP and toxicology testing results.

With simplified processes, healthcare providers are better able to follow prescribing guidelines, which have been shown to reduce opioid misuse by as much as 40 percent. LaNeve writes that increasing adherence to prescribing guidelines by only 20 percent could reduce the cost of opioid misuse by as much as $6.4 billion per year.

Create a free hfma account to read the complete article.


Subscribe to the blog
Previous Post 4 Ways Health Informatics Has Improved Patient Outcomes in the Last 5 Years
Next Post Can Pharmacogenomic Testing Improve Medication Adherence?